We are live on
!
Find out more
ACM
ADAR1 Capital Management Portfolio holdings
AUM
$1.66B
1-Year Est. Return
340.85%
This Fund
S&P 500
This Quarter
Est. Return
+8.25%
1 Year Est. Return
+340.85%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.66B
AUM Growth
+$327M
(+24%)
Cap. Flow
+$308M
Cap. Flow
% of AUM
18.5%
Top 10 Holdings %
Top 10 Hldgs %
40.47%
Holding
329
New
71
Increased
98
Reduced
59
Closed
29
Top Buys
| 1 |
Beam Therapeutics
BEAM
|
+$40.1M |
| 2 |
Crinetics Pharmaceuticals
CRNX
|
+$37.1M |
| 3 |
Denali Therapeutics
DNLI
|
+$36.2M |
| 4 |
Inspire Medical Systems
INSP
|
+$27.3M |
| 5 |
Vir Biotechnology
VIR
|
+$21.9M |
Top Sells
| 1 |
RNAM
Avidity Biosciences
RNAM
|
+$39.4M |
| 2 |
RAPT
RAPT Therapeutics
RAPT
|
+$17.3M |
| 3 |
CDTX
Cidara Therapeutics
CDTX
|
+$13.2M |
| 4 |
Fulcrum Therapeutics
FULC
|
+$10.4M |
| 5 |
Arbutus Biopharma
ABUS
|
+$9.98M |
Sector Composition
| 1 | Healthcare | 90.27% |
| 2 | Financials | 1.54% |
| 3 | Technology | 0.08% |
| 4 | Industrials | 0.08% |
| 5 | Materials | 0.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ABVX
1
Abivax
ABVX
$11.9B
| $155M | 9.33% |
1,394,019
+76,690
| +6% | +$9.08M |
|
2
Protagonist Therapeutics
PTGX
$8.71B
| $105M | 6.3% |
994,119
-55,049
| -5% | -$4.87M |
|
3
Roivant Sciences
ROIV
$25.1B
| $91M | 5.47% |
3,285,906
-143,056
| -4% | -$3.67M |
|
4
Immunovant
IMVT
$8.19B
| $66.5M | 4% |
2,679,010
+198,042
| +8% | +$5.13M |
|
5
State Street SPDR S&P 500 ETF Trust
SPY
$786B
| $49.4M | 2.97% |
75,940
+21,256
| +39% | +$14.5M |
|
|
TERN
6
DELISTED
Terns Pharmaceuticals
TERN
| $48.2M | 2.9% |
914,699
+373,084
| +69% | +$15.3M |
|
7
Cytokinetics
CYTK
$11.2B
| $41.7M | 2.51% |
632,556
+92,390
| +17% | +$5.87M |
|
|
8
Crinetics Pharmaceuticals
CRNX
$8.88B
| $41.4M | 2.49% |
1,139,331
+829,963
| +268% | +$37.1M |
|
9
Alpha Architect 1-3 Month Box ETF
BOXX
$12.7B
| $39.2M | 2.36% |
337,125
| – | – |
|
|
10
Denali Therapeutics
DNLI
$3.65B
| $35.9M | 2.16% |
1,871,455
+1,819,339
| +3,491% | +$36.2M |
|
|
11
Beam Therapeutics
BEAM
$3.17B
| $34.5M | 2.07% |
+1,446,375
| New | +$40.1M |
|
12
Zai Lab
ZLAB
$2.31B
| $26.8M | 1.61% |
1,425,367
+178,847
| +14% | +$3.31M |
|
|
SEPN
13
Septerna Inc
SEPN
$1.54B
| $26.2M | 1.57% |
1,089,818
-67,793
| -6% | -$1.78M |
|
|
14
Vir Biotechnology
VIR
$1.62B
| $24.6M | 1.48% |
+2,744,714
| New | +$21.9M |
|
|
DBVT
15
DBV Technologies
DBVT
$930M
| $21.2M | 1.27% |
+1,012,866
| New | +$21.2M |
|
|
AVR
16
Anteris Technologies
AVR
$846M
| $21M | 1.26% |
3,789,132
+2,550,355
| +206% | +$14.7M |
|
|
17
Inspire Medical Systems
INSP
$1.46B
| $20.9M | 1.26% |
405,197
+390,197
| +2,601% | +$27.3M |
|
18
Scholar Rock
SRRK
$6.48B
| $20M | 1.2% |
407,273
+337,684
| +485% | +$15.1M |
|
19
Rhythm Pharmaceuticals
RYTM
$7.52B
| $18.4M | 1.11% |
211,450
+160,101
| +312% | +$15.6M |
|
20
Spyre Therapeutics
SYRE
$8.86B
| $17.1M | 1.03% |
338,323
+304,272
| +894% | +$11.5M |
|
21
CytomX Therapeutics
CTMX
$801M
| $16M | 0.96% |
3,410,190
-772,579
| -18% | -$3.92M |
|
22
Prothena Corp
PRTA
$441M
| $15.4M | 0.92% |
1,581,443
+123,679
| +8% | +$1.13M |
|
23
Sanofi
SNY
$105B
| $15.3M | 0.92% |
316,939
+253,465
| +399% | +$11.8M |
|
24
Vaxcyte
PCVX
$8.19B
| $15.1M | 0.91% |
259,137
-56,505
| -18% | -$3.07M |
|
25
Monopar Therapeutics
MNPR
$728M
| $14.5M | 0.87% |
264,278
+30,370
| +13% | +$1.83M |
|
Similar funds
GWM
GACM
RIA
CPO
NRI
JPM
GC
FA